@inproceedings{inproceedings, title  = {{The DISPERSE2 trial: Safety, tolerability and preliminary efficacy of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel in patients with non-ST segment elevation acute coronary syndrome}},

 url = {{}},

 year = {{2005}},

 month = {{10}},

 author = {{Cannon CP and Husted S and Storey RF and Harrington RA and Hill S and Price D and Sanders N and Emanuelsson H and Peters G and DISPERSE 2 Investigators}},

 volume = {{112}},

 journal = {{CIRCULATION}},

 issue = {{17}},

 pages = {{U677-U677}},

 note = {{Accessed on 2024/12/26}}}